E2F 항체와 관련상품
산타크루즈 바이오테크놀로지는 세포 주기 조절 및 전사 제어 연구를 위한 포괄적인 E2F 항체 컬렉션을 제공합니다. E2F 항체는 웨스턴 블롯팅(WB), 면역 침전(IP), 면역 형광(IF), 파라핀 내장 섹션을 이용한 면역 조직 화학(IHCP), 유세포 분석(FCM), 효소 결합 면역 흡착 분석(ELISA) 등 다양한 응용 분야에 대해 검증되었습니다. E2F 단백질은 세포 주기 진행과 DNA 합성에 관여하는 유전자의 발현을 조절하는 데 중요한 역할을 하므로 세포 증식 및 분화를 이해하는 데 필수적인 요소입니다. E2F 활성의 조절 장애는 종종 암 및 기타 질병과 관련이 있으며, 이는 병리학적 조건에서 E2F 연구의 중요성을 강조합니다. E2F 기능을 이해하면 잠재적인 치료 표적을 밝혀내고 암 치료 전략을 발전시킬 수 있습니다. E2F 단백질을 연구하면 세포 주기 조절과 DNA 복제의 근본적인 메커니즘을 밝혀내는 데 도움이 됩니다. E2F 전사인자를 연구하면 세포 발달과 질병 진행에 대한 귀중한 통찰력을 얻을 수 있습니다. E2F 연구는 세포 성장 조절과 암 생물학에 대한 이해를 계속 확장하고 있습니다. 산타크루즈 바이오테크놀로지의 E2F 연구용 단일클론 항체는 과학자들이 세포 및 암 생물학 지식을 발전시킬 수 있도록 지원합니다.
E2F 항체
| Empty Table Header | 제품명 | 카탈로그# | ISOTYPE | EPITOPE | APPLICATIONS | Species | 引用 | RATING |
|---|---|---|---|---|---|---|---|---|
E2F1 항체 (KH95) | sc-251 | mouse IgG2a κ | 342-386 (h) | WB, IP, IF, IHC(P) | m, r, h | 767 | ||
E2F1 항체 (KH20) | sc-56662 | mouse IgG2a κ | 1-89 (h) | WB, IP | m, r, h | 11 | ||
E2F1 항체 (KH129) | sc-56661 | mouse IgG1 κ | 386-409 (h) | WB, IP, IF, IHC(P) | m, r, h | 10 | ||
E2F1 항체 (C-7) | sc-137059 | mouse IgG2b κ | 301-437 (h) | WB, IP, IF, ELISA | m, r, h | 7 | ||
E2F1 항체 (D-10) | sc-137110 | mouse IgG1 κ | 301-437 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
E2F1 항체 (E-2) | sc-137060 | mouse IgG2b κ | 301-437 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
E2F-2 항체 (TFE-25) | sc-9967 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 39 | ||
E2F-2 항체 (A-6) | sc-515402 | mouse IgG2a κ | 414-437 (h) | WB, IP, IF, ELISA | m, r, h | 1 | ||
E2F-2 항체 (H-9) | sc-514477 | mouse IgG1 κ | 1-120 (h) | WB, IP, IF, ELISA | h | new | ||
E2F-2 항체 (TFE22) | sc-56664 | mouse IgG1 κ | FL (h) | WB, IP, IF, ELISA | m, r, h | new | ||
E2F-2 항체 (CC1) | sc-69678 | mouse IgG1 κ | (h) | WB, IP | h | new | ||
E2F-2 항체 (CC11) | sc-56663 | mouse IgG2a κ | (h) | WB, IP | h | new | ||
E2F-3 항체 (PG30) | sc-56665 | mouse IgG2a κ | (h) | WB, IP | m, r, h | 14 | ||
E2F-3 항체 (D-2) | sc-28308 | mouse IgG2a κ | 1-110 (h) | WB, IP, IF, ELISA | m, r, h | 6 | ||
E2F-3 항체 (PG14) | sc-69683 | mouse IgG2a κ | (h) | WB, IP | m, r, h | 2 | ||
E2F-3 항체 (0.N.263) | sc-71018 | mouse IgG2a κ | (h) | WB, IP | m, r, h | new | ||
E2F-3 항체 (PG37) | sc-69684 | mouse IgG2a κ | (h) | WB, IP | m, r, h | 2 | ||
E2F-3 항체 (TFE36) | sc-56666 | mouse IgG2b κ | FL (h) | WB, IP, IF, ELISA | m, r, h | 1 | ||
E2F-4 항체 (D-7) | sc-398543 | mouse IgG1 κ | 385-413 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 6 | ||
E2F-4 항체 (RK-13) | sc-511 | mouse IgG2a κ | 108-300 (h) | WB, IP, IF, IHC(P) | m, r, h | 15 | ||
E2F-4 항체 (D-3) | sc-6851 | mouse IgG1 κ | 108-300 (h) | WB, IP, IF, IHC(P) | m, r, h | 8 | ||
E2F-4 항체 (WUF11) | sc-56669 | mouse IgG1 κ | (h) | WB, IP | m, r, h | 2 | ||
E2F-4 항체 (TFE-42) | sc-56668 | mouse IgG1 κ | FL (h) | WB, IP, IF, ELISA | m, r, h | new | ||
E2F-4 항체 (WUF2) | sc-69685 | mouse IgG1 κ | (h) | WB, IP | m, r, h | new | ||
E2F-4 항체 (WUF3) | sc-56670 | mouse IgG1 κ | (h) | WB, IP | h | new | ||
E2F-4 항체 (WUF10) | sc-69686 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P) | m, r, h | 2 | ||
E2F-5 항체 (C-8) | sc-374268 | mouse IgG2a κ | 303-331 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 7 | ||
E2F-5 항체 (MH-5) | sc-968 | mouse IgG1 κ | 89-346 (h) | WB, IP, IF | m, r, h | 25 | ||
E2F-5 항체 (H-1) | sc-271497 | mouse IgG1 κ | 89-200 (h) | WB, IP, IF, ELISA | m, r, h | 1 | ||
E2F-6 항체 (TFE61) | sc-53273 | mouse IgG1 κ | (h) | WB, IP | h | 8 | ||
E2F-6 항체 (E-5) | sc-390022 | mouse IgG2b κ | 233-272 (m) | WB, IP, IF, ELISA | m, r | 1 | ||
E2F-6 항체 (C-10) | sc-398662 | mouse IgG1 κ | 232-281 (h) | WB, IP, IF, ELISA | h | 1 | ||
E2F-6 항체 (E-3) | sc-398677 | mouse IgG2b κ | 232-281 (h) | WB, IP, IF, ELISA | h | new | ||
E2F-8 항체 (B-9) | sc-514064 | mouse IgG1 λ | 664-764 (h) | WB, IP, IF, ELISA | m, r, h | 3 | ||
E2F-8 항체 (9) | sc-130313 | mouse IgG1 κ | (h) | WB, IP, ELISA | h | new |
E2F CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 제품명 | 카탈로그# | Species | APPLICATIONS | MARKER | 引用 | RATING |
|---|---|---|---|---|---|---|---|
E2F1 CRISPR/Cas9 케이오 플라스미드 (h) | sc-400123 | h | Gene Knockout | GFP | 0 | ||
E2F1 HDR 플라스미드 (h) | sc-400123-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
E2F1 더블 틈내기효소 플라스미드 (h) | sc-400123-NIC | h | Gene Knockout | Puromycin | 0 | ||
E2F1 더블 틈내기효소 플라스미드 (h2) | sc-400123-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
E2F1 CRISPR/Cas9 케이오 플라스미드 (m) | sc-420085 | m | Gene Knockout | GFP | 0 | ||
E2F1 HDR 플라스미드 (m) | sc-420085-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
E2F1 더블 틈내기효소 플라스미드 (m) | sc-420085-NIC | m | Gene Knockout | Puromycin | 0 | ||
E2F1 더블 틈내기효소 플라스미드 (m2) | sc-420085-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
E2F-2 CRISPR/Cas9 케이오 플라스미드 (h) | sc-400880 | h | Gene Knockout | GFP | 0 | ||
E2F-2 HDR Plasmid (h) | sc-400880-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
E2F-2 Double Nickase Plasmid (h) | sc-400880-NIC | h | Gene Knockout | Puromycin | 0 | ||
E2F-2 Double Nickase Plasmid (h2) | sc-400880-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
E2F-2 CRISPR/Cas9 케이오 플라스미드 (m) | sc-433933 | m | Gene Knockout | GFP | 0 | ||
E2F-2 HDR 플라스미드 (m) | sc-433933-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
E2F-2 더블 틈내기효소 플라스미드 (m) | sc-433933-NIC | m | Gene Knockout | Puromycin | 0 | ||
E2F-2 더블 틈내기효소 플라스미드 (m2) | sc-433933-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
E2F-3 CRISPR/Cas9 케이오 플라스미드 (h) | sc-400934 | h | Gene Knockout | GFP | 0 | ||
E2F-3 HDR Plasmid (h) | sc-400934-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
E2F-3 Double Nickase Plasmid (h) | sc-400934-NIC | h | Gene Knockout | Puromycin | 0 | ||
E2F-3 Double Nickase Plasmid (h2) | sc-400934-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
E2F-3 CRISPR/Cas9 케이오 플라스미드 (m) | sc-420086 | m | Gene Knockout | GFP | 0 | ||
E2F-3 HDR 플라스미드 (m) | sc-420086-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
E2F-3 더블 틈내기효소 플라스미드 (m) | sc-420086-NIC | m | Gene Knockout | Puromycin | 0 | ||
E2F-3 더블 틈내기효소 플라스미드 (m2) | sc-420086-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
E2F-4 CRISPR/Cas9 케이오 플라스미드 (h) | sc-400851 | h | Gene Knockout | GFP | 0 | ||
E2F-4 HDR Plasmid (h) | sc-400851-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
E2F-4 Double Nickase Plasmid (h) | sc-400851-NIC | h | Gene Knockout | Puromycin | 0 | ||
E2F-4 Double Nickase Plasmid (h2) | sc-400851-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
E2F-4 CRISPR/Cas9 케이오 플라스미드 (m) | sc-430537 | m | Gene Knockout | GFP | 0 | ||
E2F-4 HDR 플라스미드 (m) | sc-430537-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
E2F-4 더블 틈내기효소 플라스미드 (m) | sc-430537-NIC | m | Gene Knockout | Puromycin | 0 | ||
E2F-4 더블 틈내기효소 플라스미드 (m2) | sc-430537-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
E2F-5 CRISPR/Cas9 케이오 플라스미드 (h) | sc-401915 | h | Gene Knockout | GFP | 0 | ||
E2F-5 HDR Plasmid (h) | sc-401915-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
E2F-5 Double Nickase Plasmid (h) | sc-401915-NIC | h | Gene Knockout | Puromycin | 0 | ||
E2F-5 Double Nickase Plasmid (h2) | sc-401915-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
E2F-5 CRISPR/Cas9 케이오 플라스미드 (m) | sc-420087 | m | Gene Knockout | GFP | 0 | ||
E2F-5 HDR 플라스미드 (m) | sc-420087-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
E2F-5 더블 틈내기효소 플라스미드 (m) | sc-420087-NIC | m | Gene Knockout | Puromycin | 0 | ||
E2F-5 더블 틈내기효소 플라스미드 (m2) | sc-420087-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
E2F-6 CRISPR/Cas9 케이오 플라스미드 (h) | sc-403615 | h | Gene Knockout | GFP | 0 | ||
E2F-6 HDR 플라스미드 (h) | sc-403615-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
E2F-6 더블 틈내기효소 플라스미드 (h) | sc-403615-NIC | h | Gene Knockout | Puromycin | 0 | ||
E2F-6 더블 틈내기효소 플라스미드 (h2) | sc-403615-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
E2F-6 CRISPR/Cas9 케이오 플라스미드 (m) | sc-424446 | m | Gene Knockout | GFP | 0 | ||
E2F-6 HDR 플라스미드 (m) | sc-424446-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
E2F-6 더블 틈내기효소 플라스미드 (m) | sc-424446-NIC | m | Gene Knockout | Puromycin | 0 | ||
E2F-6 더블 틈내기효소 플라스미드 (m2) | sc-424446-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
E2F-7 CRISPR/Cas9 케이오 플라스미드 (h) | sc-401855 | h | Gene Knockout | GFP | 0 | ||
E2F-7 HDR Plasmid (h) | sc-401855-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
E2F-7 Double Nickase Plasmid (h) | sc-401855-NIC | h | Gene Knockout | Puromycin | 0 | ||
E2F-7 Double Nickase Plasmid (h2) | sc-401855-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
E2F-7 CRISPR/Cas9 케이오 플라스미드 (m) | sc-424645 | m | Gene Knockout | GFP | 0 | ||
E2F-7 HDR 플라스미드 (m) | sc-424645-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
E2F-7 더블 틈내기효소 플라스미드 (m) | sc-424645-NIC | m | Gene Knockout | Puromycin | 0 | ||
E2F-7 더블 틈내기효소 플라스미드 (m2) | sc-424645-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
E2F-8 CRISPR/Cas9 케이오 플라스미드 (h) | sc-406972 | h | Gene Knockout | GFP | 0 | ||
E2F-8 CRISPR/Cas9 케이오 플라스미드 (h2) | sc-406972-KO-2 | h | Gene Knockout | GFP | 0 | ||
E2F-8 HDR 플라스미드 (h2) | sc-406972-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
E2F-8 더블 틈내기효소 플라스미드 (h) | sc-406972-NIC | h | Gene Knockout | Puromycin | 0 | ||
E2F-8 더블 틈내기효소 플라스미드 (h2) | sc-406972-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
E2F-8 CRISPR/Cas9 케이오 플라스미드 (m) | sc-430884 | m | Gene Knockout | GFP | 0 | ||
E2F-8 HDR 플라스미드 (m) | sc-430884-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
E2F-8 더블 틈내기효소 플라스미드 (m) | sc-430884-NIC | m | Gene Knockout | Puromycin | 0 | ||
E2F-8 더블 틈내기효소 플라스미드 (m2) | sc-430884-NIC-2 | m | Gene Knockout | Puromycin | 0 |
E2F CRISPR Activation Products
| Empty Table Header | 제품명 | 카탈로그# | Species | APPLICATIONS | MARKER | 引用 | RATING |
|---|---|---|---|---|---|---|---|
E2F1 CRISPR 활성화 플라스미드(h) | sc-400123-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F1 CRISPR 활성화 플라스미드(h2) | sc-400123-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F1 렌티바이러스의 활성화 입자 (h) | sc-400123-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F1 렌티바이러스의 활성화 입자 (h2) | sc-400123-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F1 CRISPR 활성화 플라스미드(m) | sc-420085-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F1 CRISPR 활성화 플라스미드(m2) | sc-420085-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F1 렌티바이러스의 활성화 입자 (m) | sc-420085-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F1 렌티바이러스의 활성화 입자 (m2) | sc-420085-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-2 CRISPR Activation Plasmid (h) | sc-400880-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-2 CRISPR Activation Plasmid (h2) | sc-400880-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-2 Lentiviral Activation Particles (h) | sc-400880-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-2 Lentiviral Activation Particles (h2) | sc-400880-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-2 CRISPR 활성화 플라스미드(m) | sc-433933-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-2 CRISPR 활성화 플라스미드(m2) | sc-433933-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-2 렌티바이러스의 활성화 입자 (m) | sc-433933-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-2 렌티바이러스의 활성화 입자 (m2) | sc-433933-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-3 CRISPR Activation Plasmid (h) | sc-400934-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-3 CRISPR Activation Plasmid (h2) | sc-400934-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-3 Lentiviral Activation Particles (h) | sc-400934-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-3 Lentiviral Activation Particles (h2) | sc-400934-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-3 CRISPR 활성화 플라스미드(m) | sc-420086-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-3 CRISPR 활성화 플라스미드(m2) | sc-420086-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-3 렌티바이러스의 활성화 입자 (m) | sc-420086-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-3 렌티바이러스의 활성화 입자 (m2) | sc-420086-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-4 CRISPR Activation Plasmid (h) | sc-400851-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-4 CRISPR Activation Plasmid (h2) | sc-400851-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-4 Lentiviral Activation Particles (h) | sc-400851-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-4 Lentiviral Activation Particles (h2) | sc-400851-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-4 CRISPR 활성화 플라스미드(m) | sc-430537-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-4 CRISPR 활성화 플라스미드(m2) | sc-430537-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-4 렌티바이러스의 활성화 입자 (m) | sc-430537-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-4 렌티바이러스의 활성화 입자 (m2) | sc-430537-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-5 CRISPR Activation Plasmid (h) | sc-401915-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-5 CRISPR Activation Plasmid (h2) | sc-401915-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-5 Lentiviral Activation Particles (h) | sc-401915-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-5 Lentiviral Activation Particles (h2) | sc-401915-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-5 CRISPR 활성화 플라스미드(m) | sc-420087-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-5 CRISPR 활성화 플라스미드(m2) | sc-420087-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-5 렌티바이러스의 활성화 입자 (m) | sc-420087-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-5 렌티바이러스의 활성화 입자 (m2) | sc-420087-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-6 CRISPR 활성화 플라스미드(h) | sc-403615-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-6 CRISPR 활성화 플라스미드(h2) | sc-403615-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-6 렌티바이러스의 활성화 입자 (h) | sc-403615-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-6 렌티바이러스의 활성화 입자 (h2) | sc-403615-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-6 CRISPR 활성화 플라스미드(m) | sc-424446-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-6 CRISPR 활성화 플라스미드(m2) | sc-424446-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-6 렌티바이러스의 활성화 입자 (m) | sc-424446-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-6 렌티바이러스의 활성화 입자 (m2) | sc-424446-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-7 CRISPR Activation Plasmid (h) | sc-401855-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-7 CRISPR Activation Plasmid (h2) | sc-401855-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-7 Lentiviral Activation Particles (h) | sc-401855-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-7 Lentiviral Activation Particles (h2) | sc-401855-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-7 CRISPR 활성화 플라스미드(m) | sc-424645-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-7 CRISPR 활성화 플라스미드(m2) | sc-424645-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-7 렌티바이러스의 활성화 입자 (m) | sc-424645-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-7 렌티바이러스의 활성화 입자 (m2) | sc-424645-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-8 CRISPR 활성화 플라스미드(h) | sc-406972-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-8 CRISPR 활성화 플라스미드(h2) | sc-406972-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-8 렌티바이러스의 활성화 입자 (h) | sc-406972-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-8 렌티바이러스의 활성화 입자 (h2) | sc-406972-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-8 CRISPR 활성화 플라스미드(m) | sc-430884-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-8 CRISPR 활성화 플라스미드(m2) | sc-430884-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-8 렌티바이러스의 활성화 입자 (m) | sc-430884-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E2F-8 렌티바이러스의 활성화 입자 (m2) | sc-430884-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
E2F siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | 제품명 | 카탈로그# | Species | APPLICATIONS | MARKER | 引用 | RATING |
|---|---|---|---|---|---|---|---|
E2F1 siRNA (h) | sc-29297 | h | Gene Silencing | N/A | 54 | ||
E2F1 siRNA (h2) | sc-44258 | h | Gene Silencing | N/A | 2 | ||
E2F1 shRNA 플라스미드 (h) | sc-29297-SH | h | Gene Silencing | Puromycin | 54 | ||
E2F1 shRNA 플라스미드 (h2) | sc-44258-SH | h | Gene Silencing | Puromycin | 2 | ||
E2F1 shRNA (h)렌티바이러스의 입자 | sc-29297-V | h | Gene Silencing | Puromycin | 54 | ||
E2F1 shRNA (h2)렌티바이러스의 입자 | sc-44258-V | h | Gene Silencing | Puromycin | 2 | ||
E2F1 siRNA (m) | sc-35247 | m | Gene Silencing | N/A | 8 | ||
E2F1 shRNA 플라스미드 (m) | sc-35247-SH | m | Gene Silencing | Puromycin | 8 | ||
E2F1 shRNA (m)렌티바이러스의 입자 | sc-35247-V | m | Gene Silencing | Puromycin | 8 | ||
E2F1 siRNA (r) | sc-61861 | r | Gene Silencing | N/A | 3 | ||
E2F1 shRNA 플라스미드 (r) | sc-61861-SH | r | Gene Silencing | Puromycin | 3 | ||
E2F1 shRNA (r)렌티바이러스의 입자 | sc-61861-V | r | Gene Silencing | Puromycin | 3 | ||
E2F1 siRNA (bovine) | sc-270478 | bovine | Gene Silencing | N/A | 0 | ||
E2F1 shRNA 플라스미드 (bovine) | sc-270478-SH | bovine | Gene Silencing | Puromycin | 0 | ||
E2F1 shRNA (bovine)렌티바이러스의 입자 | sc-270478-V | bovine | Gene Silencing | Puromycin | 0 | ||
E2F-2 siRNA (h) | sc-29298 | h | Gene Silencing | N/A | 3 | ||
E2F-2 shRNA 플라스미드 (h) | sc-29298-SH | h | Gene Silencing | Puromycin | 3 | ||
E2F-2 shRNA (h)렌티바이러스의 입자 | sc-29298-V | h | Gene Silencing | Puromycin | 3 | ||
E2F-2 siRNA (m) | sc-29299 | m | Gene Silencing | N/A | 2 | ||
E2F-2 shRNA 플라스미드 (m) | sc-29299-SH | m | Gene Silencing | Puromycin | 2 | ||
E2F-2 shRNA (m)렌티바이러스의 입자 | sc-29299-V | m | Gene Silencing | Puromycin | 2 | ||
E2F-3 siRNA (h) | sc-37817 | h | Gene Silencing | N/A | 7 | ||
E2F-3 shRNA 플라스미드 (h) | sc-37817-SH | h | Gene Silencing | Puromycin | 7 | ||
E2F-3 shRNA (h)렌티바이러스의 입자 | sc-37817-V | h | Gene Silencing | Puromycin | 7 | ||
E2F-3 siRNA (m) | sc-37818 | m | Gene Silencing | N/A | 0 | ||
E2F-3 shRNA 플라스미드 (m) | sc-37818-SH | m | Gene Silencing | Puromycin | 0 | ||
E2F-3 shRNA (m)렌티바이러스의 입자 | sc-37818-V | m | Gene Silencing | Puromycin | 0 | ||
E2F-4 siRNA (h) | sc-29300 | h | Gene Silencing | N/A | 2 | ||
E2F-4 shRNA 플라스미드 (h) | sc-29300-SH | h | Gene Silencing | Puromycin | 2 | ||
E2F-4 shRNA (h)렌티바이러스의 입자 | sc-29300-V | h | Gene Silencing | Puromycin | 2 | ||
E2F-4 siRNA (m) | sc-35248 | m | Gene Silencing | N/A | 1 | ||
E2F-4 shRNA 플라스미드 (m) | sc-35248-SH | m | Gene Silencing | Puromycin | 1 | ||
E2F-4 shRNA (m)렌티바이러스의 입자 | sc-35248-V | m | Gene Silencing | Puromycin | 1 | ||
E2F-5 siRNA (h) | sc-35250 | h | Gene Silencing | N/A | 0 | ||
E2F-5 shRNA 플라스미드 (h) | sc-35250-SH | h | Gene Silencing | Puromycin | 0 | ||
E2F-5 shRNA (h)렌티바이러스의 입자 | sc-35250-V | h | Gene Silencing | Puromycin | 0 | ||
E2F-5 siRNA (m) | sc-35249 | m | Gene Silencing | N/A | 0 | ||
E2F-5 shRNA 플라스미드 (m) | sc-35249-SH | m | Gene Silencing | Puromycin | 0 | ||
E2F-5 shRNA (m)렌티바이러스의 입자 | sc-35249-V | m | Gene Silencing | Puromycin | 0 | ||
E2F-6 siRNA (h) | sc-37819 | h | Gene Silencing | N/A | 0 | ||
E2F-6 shRNA 플라스미드 (h) | sc-37819-SH | h | Gene Silencing | Puromycin | 0 | ||
E2F-6 shRNA (h)렌티바이러스의 입자 | sc-37819-V | h | Gene Silencing | Puromycin | 0 | ||
E2F-6 siRNA (m) | sc-37820 | m | Gene Silencing | N/A | 0 | ||
E2F-6 shRNA 플라스미드 (m) | sc-37820-SH | m | Gene Silencing | Puromycin | 0 | ||
E2F-6 shRNA (m)렌티바이러스의 입자 | sc-37820-V | m | Gene Silencing | Puromycin | 0 | ||
E2F-7 siRNA (h) | sc-44590 | h | Gene Silencing | N/A | 1 | ||
E2F-7 shRNA 플라스미드 (h) | sc-44590-SH | h | Gene Silencing | Puromycin | 1 | ||
E2F-7 shRNA (h)렌티바이러스의 입자 | sc-44590-V | h | Gene Silencing | Puromycin | 1 | ||
E2F-7 siRNA (m) | sc-44591 | m | Gene Silencing | N/A | 0 | ||
E2F-7 shRNA 플라스미드 (m) | sc-44591-SH | m | Gene Silencing | Puromycin | 0 | ||
E2F-7 shRNA (m)렌티바이러스의 입자 | sc-44591-V | m | Gene Silencing | Puromycin | 0 | ||
E2F-8 siRNA (h) | sc-96849 | h | Gene Silencing | N/A | 1 | ||
E2F-8 shRNA 플라스미드 (h) | sc-96849-SH | h | Gene Silencing | Puromycin | 1 | ||
E2F-8 shRNA (h)렌티바이러스의 입자 | sc-96849-V | h | Gene Silencing | Puromycin | 1 | ||
E2F-8 siRNA (m) | sc-143248 | m | Gene Silencing | N/A | 0 | ||
E2F-8 shRNA 플라스미드 (m) | sc-143248-SH | m | Gene Silencing | Puromycin | 0 | ||
E2F-8 shRNA (m)렌티바이러스의 입자 | sc-143248-V | m | Gene Silencing | Puromycin | 0 |
E2F Oligonucleotides
| Empty Table Header | 제품명 | CONSENSUS CAT. # | MUTANT CAT. # | MUTANT CONSENSUS | BINDING MOTIF | 引用 | RATING |
|---|---|---|---|---|---|---|---|
E2F-1 consensus oligonucleotide | sc-2507 | sc-2508 | 5-’ATT TAA GTT TCG CGC CCT TTC TCA A-3’ | "CG"→"AT" | 47 |